BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9511979)

  • 1. Early treatment of Menkes disease with parenteral copper-histidine: long-term follow-up of four treated patients.
    Christodoulou J; Danks DM; Sarkar B; Baerlocher KE; Casey R; Horn N; Tümer Z; Clarke JT
    Am J Med Genet; 1998 Mar; 76(2):154-64. PubMed ID: 9511979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper-histidine therapy for Menkes disease.
    Sarkar B; Lingertat-Walsh K; Clarke JT
    J Pediatr; 1993 Nov; 123(5):828-30. PubMed ID: 8229500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menkes' disease: long-term treatment with copper and D-penicillamine.
    Nadal D; Baerlocher K
    Eur J Pediatr; 1988 Aug; 147(6):621-5. PubMed ID: 3181204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper-histidine treatment of Menkes disease.
    Garnica A; Chan WY; Rennert O
    J Pediatr; 1994 Aug; 125(2):336-8. PubMed ID: 8093166
    [No Abstract]   [Full Text] [Related]  

  • 5. [Manufacturing and stability of copper-histidine solution for treatment of Menkes' Kinky Hair Syndrome].
    Hoppe-Tichy T; Nguyen TH; Hentze BW; Lorke M
    Pharmazie; 2005 Mar; 60(3):205-7. PubMed ID: 15801674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menkes' kinky-hair disease: radiologic findings in a patient treated with copper histidinate.
    Waslen TA; Houston CS; Tchang S
    Can Assoc Radiol J; 1995 Apr; 46(2):114-7. PubMed ID: 7704673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 37-year-old Menkes disease patient-Residual ATP7A activity and early copper administration as key factors in beneficial treatment.
    Tümer Z; Petris M; Zhu S; Mercer J; Bukrinski J; Bilz S; Baerlocher K; Horn N; Møller LB
    Clin Genet; 2017 Nov; 92(5):548-553. PubMed ID: 28657131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menkes disease after copper histidine replacement therapy: case report.
    George DH; Casey RE
    Pediatr Dev Pathol; 2001; 4(3):281-8. PubMed ID: 11370266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper concentration of liver tissue under long-term copper-histidine therapy in a patient with Menkes disease.
    Kroepfl T; Mair E; Deutsch J; Brunner-Krainz M; Paschke E; Plecko B
    J Inherit Metab Dis; 2006 Aug; 29(4):593. PubMed ID: 16786254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT manifestations of Menkes' kinky hair syndrome (trichopoliodystrophy).
    Farrelly C; Stringer DA; Daneman A; Fitz CR; Sass-Kortsak A
    J Can Assoc Radiol; 1984 Dec; 35(4):406-8. PubMed ID: 6526854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of copper-histidine therapy on brain metabolism in a patient with Menkes disease: a proton magnetic resonance spectroscopic study.
    Munakata M; Sakamoto O; Kitamura T; Ishitobi M; Yokoyama H; Haginoya K; Togashi N; Tamura H; Higano S; Takahashi S; Ohura T; Kobayashi Y; Onuma A; Iinuma K
    Brain Dev; 2005 Jun; 27(4):297-300. PubMed ID: 15862194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive Menkes disease variant with occipital horns: delineation of natural history and clinical phenotype.
    Proud VK; Mussell HG; Kaler SG; Young DW; Percy AK
    Am J Med Genet; 1996 Oct; 65(1):44-51. PubMed ID: 8914740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early copper histidine therapy in classic Menkes disease.
    Sarkar B
    Ann Neurol; 1997 Jan; 41(1):134-6. PubMed ID: 9005880
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Menkes disease with parenteral copper histidine.
    Kirodian BG; Gogtay NJ; Udani VP; Kshirsagar NA
    Indian Pediatr; 2002 Feb; 39(2):183-5. PubMed ID: 11867850
    [No Abstract]   [Full Text] [Related]  

  • 15. Long surviving classical Menkes disease treated with weekly intravenous copper therapy.
    Ogata R; Chong PF; Maeda K; Imagi T; Nakamura R; Kawamura N; Kira R
    J Trace Elem Med Biol; 2019 Jul; 54():172-174. PubMed ID: 31109608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical consequences of copper-histidine therapy in Menkes disease.
    Kreuder J; Otten A; Fuder H; Tümer Z; Tønnesen T; Horn N; Dralle D
    Eur J Pediatr; 1993 Oct; 152(10):828-32. PubMed ID: 8223785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early copper therapy in classic Menkes disease patients with a novel splicing mutation.
    Kaler SG; Buist NR; Holmes CS; Goldstein DS; Miller RC; Gahl WA
    Ann Neurol; 1995 Dec; 38(6):921-8. PubMed ID: 8526465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menkes' disease: report of a case and determination of eumelanin and pheomelanin in hypopigmented hair.
    Tomita Y; Kondo Y; Ito S; Hara M; Yoshimura T; Igarashi H; Tagami H
    Dermatology; 1992; 185(1):66-8. PubMed ID: 1638075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of disulfiram treatment in patients with Menkes disease and occipital horn syndrome.
    Ogawa E; Kodama H
    J Trace Elem Med Biol; 2012 Jun; 26(2-3):102-4. PubMed ID: 22575542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function in patients with Menkes disease.
    Ozawa H; Kodama H; Kawaguchi H; Mochizuki T; Kobayashi M; Igarashi T
    Eur J Pediatr; 2003 Jan; 162(1):51-2. PubMed ID: 12607531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.